−21.29 MUSD
About Calithera Biosciences, Inc.
Sector
Industry
CEO
Susan M. Molineaux
Website
Headquarters
South San Francisco
Employees (FY)
10
Founded
2010
FIGI
BBG0071GQ6D1
Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. It also focuses on researching small molecule oncology compounds with a biomarker-driven approach that targets genetic vulnerabilities in cancer cells to deliver new therapies for patients suffering from aggressive hematologic. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CALA is 0.0251 USD — it has decreased by 37.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Calithera Biosciences, Inc. stocks are traded under the ticker CALA.
Calithera Biosciences, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
CALA stock is 59.68% volatile and has beta coefficient of −1.98. Check out the list of the most volatile stocks — is Calithera Biosciences, Inc. there?
CALA earnings for the last quarter are −1.59 USD per share, whereas the estimation was −2.45 USD resulting in a 35.17% surprise. The estimated earnings for the next quarter are −1.93 USD per share. See more details about Calithera Biosciences, Inc. earnings.
Calithera Biosciences, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 750.00 K USD.
Yes, you can track Calithera Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
CALA stock has risen by 25.25% compared to the previous week, the last month showed zero change in price, over the last year Calithera Biosciences, Inc. has showed a 37.38% decrease.
No, CALA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CALA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Calithera Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 10.00 employees. See our rating of the largest employees — is Calithera Biosciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Calithera Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Calithera Biosciences, Inc. stock shows the sell signal. See more of Calithera Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.